Deals
Pharma’s Comeback Deals Keep Drug M&A on Track to Reach Records
Fast and Furious: Drug Deals Race Ahead
This article is for subscribers only.
The drug giants that abandoned more than $200 billion of takeover attempts last year didn’t spend long licking their wounds.
Merger-hungry companies from AbbVie Inc. to Valeant Pharmaceuticals International Inc. spent the first three months of 2015 scooping up smaller targets, and driving an overall rise in takeover volumes, after failing to seal a string of more ambitious deals in 2014.